
Grant Sitta
Examiner (ID: 10734, Phone: (571)270-1542 , Office: P/2622 )
| Most Active Art Unit | 2622 |
| Art Unit(s) | 2694, 2622, 2629 |
| Total Applications | 1002 |
| Issued Applications | 677 |
| Pending Applications | 79 |
| Abandoned Applications | 280 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17315971
[patent_doc_number] => 20210405019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => OBTAINING INFORMATION FROM A BIOLOGICAL SAMPLE IN A FLOW CELL
[patent_app_type] => utility
[patent_app_number] => 17/470228
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470228 | Obtaining information from a biological sample in a flow cell | Sep 8, 2021 | Issued |
Array
(
[id] => 17297925
[patent_doc_number] => 20210393764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Immunogenic Compositions for Use in Pneumococcal Vaccines
[patent_app_type] => utility
[patent_app_number] => 17/463691
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17463691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/463691 | Immunogenic Compositions for Use in Pneumococcal Vaccines | Aug 31, 2021 | Abandoned |
Array
(
[id] => 17299475
[patent_doc_number] => 20210395314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => MODIFIED BACTERIAL MICROCOMPARTMENT SHELL PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/458131
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458131 | Modified bacterial microcompartment shell protein | Aug 25, 2021 | Issued |
Array
(
[id] => 18691024
[patent_doc_number] => 20230321212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/042561
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042561
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042561 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | Aug 22, 2021 | Pending |
Array
(
[id] => 17297922
[patent_doc_number] => 20210393761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/406765
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406765 | Isolated polypeptide of the toxin A and toxin B proteins of | Aug 18, 2021 | Issued |
Array
(
[id] => 20378984
[patent_doc_number] => 20250361477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-27
[patent_title] => PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL
[patent_app_type] => utility
[patent_app_number] => 18/040378
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040378
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040378 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | Aug 9, 2021 | Pending |
Array
(
[id] => 18801325
[patent_doc_number] => 11834477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity
[patent_app_type] => utility
[patent_app_number] => 17/397816
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 9115
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397816 | Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity | Aug 8, 2021 | Issued |
Array
(
[id] => 17244772
[patent_doc_number] => 20210364515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/388733
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17388733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/388733 | OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS | Jul 28, 2021 | Abandoned |
Array
(
[id] => 18444722
[patent_doc_number] => 11680282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Apparatus and method for distinguishing antibiotics susceptibility
[patent_app_type] => utility
[patent_app_number] => 17/386687
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 5502
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386687 | Apparatus and method for distinguishing antibiotics susceptibility | Jul 27, 2021 | Issued |
Array
(
[id] => 17214495
[patent_doc_number] => 20210347832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ARTICLES COMPRISING A SILK POLYPEPTIDE FOR ANTIGEN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/383926
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383926 | Articles comprising a silk polypeptide for antigen delivery | Jul 22, 2021 | Issued |
Array
(
[id] => 17241983
[patent_doc_number] => 20210361726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => INHALED RESPIRATORY PROBIOTICS FOR LUNG DISEASES OF INFANCY, CHILDHOOD AND ADULTHOOD
[patent_app_type] => utility
[patent_app_number] => 17/384272
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384272 | Inhaled respiratory probiotics for lung diseases of infancy, childhood and adulthood | Jul 22, 2021 | Issued |
Array
(
[id] => 18852726
[patent_doc_number] => 11850278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Compositions comprising
[patent_app_type] => utility
[patent_app_number] => 17/374424
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 62
[patent_no_of_words] => 62150
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374424 | Compositions comprising | Jul 12, 2021 | Issued |
Array
(
[id] => 17577044
[patent_doc_number] => 20220133899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => PREPARATION OF MAYTANSINOID ANTIBODY CONJUGATES BY A ONE-STEP PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/371151
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371151 | Preparation of maytansinoid antibody conjugates by a one-step process | Jul 8, 2021 | Issued |
Array
(
[id] => 18673158
[patent_doc_number] => 20230310650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => Bacterial Vehicle for Engineering of Non-Phagocytic Immune Cells
[patent_app_type] => utility
[patent_app_number] => 18/014649
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014649
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014649 | Bacterial Vehicle for Engineering of Non-Phagocytic Immune Cells | Jul 6, 2021 | Pending |
Array
(
[id] => 17334663
[patent_doc_number] => 20220000994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => Peptide Conjugated Particles
[patent_app_type] => utility
[patent_app_number] => 17/364351
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364351 | Peptide conjugated particles | Jun 29, 2021 | Issued |
Array
(
[id] => 19018270
[patent_doc_number] => 20240074441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => AGRICULTURAL COMPOSITION COMPRISED OF THREE SPECIES OF BACILLUS AND MIXED TOCOPHEROLS OF VEGETABLE ORIGIN, WITH POTENTIALIZER EFFECT OF THE BIOFUNGICIDE MECHANISMS AND UV PROTECTION FOR AGRICULTURAL APPLICATION, AND PROCESS OF PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 18/254555
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254555 | AGRICULTURAL COMPOSITION COMPRISED OF THREE SPECIES OF BACILLUS AND MIXED TOCOPHEROLS OF VEGETABLE ORIGIN, WITH POTENTIALIZER EFFECT OF THE BIOFUNGICIDE MECHANISMS AND UV PROTECTION FOR AGRICULTURAL APPLICATION, AND PROCESS OF PRODUCING SAME | Jun 22, 2021 | Issued |
Array
(
[id] => 17256810
[patent_doc_number] => 20210369795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK FOR CHECKPOINT BLOCKADE THERAPY ASSOCIATED COLITIS
[patent_app_type] => utility
[patent_app_number] => 17/350952
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350952 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK FOR CHECKPOINT BLOCKADE THERAPY ASSOCIATED COLITIS | Jun 16, 2021 | Abandoned |
Array
(
[id] => 18477077
[patent_doc_number] => 11690801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Adherent oral pharmabiotic delivery strip
[patent_app_type] => utility
[patent_app_number] => 17/344062
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5768
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344062
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344062 | Adherent oral pharmabiotic delivery strip | Jun 9, 2021 | Issued |
Array
(
[id] => 17290955
[patent_doc_number] => 20210386794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/344065
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344065
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344065 | Cancer therapy | Jun 9, 2021 | Issued |
Array
(
[id] => 19032505
[patent_doc_number] => 20240082320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => ENTEROCOCCUS LACTIS, DRUG FOR PREVENTING OR TREATING TUMOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/273216
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273216 | ENTEROCOCCUS LACTIS, DRUG FOR PREVENTING OR TREATING TUMOR AND USE THEREOF | Jun 7, 2021 | Pending |